Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.

Turner D, Levine A, Kolho KL, Shaoul R, Ledder O.

J Crohns Colitis. 2014 Nov;8(11):1464-70. doi: 10.1016/j.crohns.2014.05.010. Epub 2014 Jun 20.

PMID:
24958064
2.

Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.

Uehara T, Kato K, Ohkusa T, Sugitani M, Ishii Y, Nemoto N, Moriyama M.

J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S62-6. doi: 10.1111/j.1440-1746.2010.06231.x.

PMID:
20586868
3.

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.

Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P.

Intern Med J. 2014 May;44(5):464-70. doi: 10.1111/imj.12397.

PMID:
24612209
4.

Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.

Kato K, Ohkusa T, Terao S, Chiba T, Murakami K, Yanaka A, Uehara T, Ishii Y, Soma M, Tajiri H.

Aliment Pharmacol Ther. 2014 May;39(9):949-56. doi: 10.1111/apt.12688. Epub 2014 Mar 13.

5.

Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.

Wine E, Mack DR, Hyams J, Otley AR, Markowitz J, Crandall WV, Leleiko N, Muise AM, Griffiths AM, Turner D.

J Crohns Colitis. 2013 Dec;7(11):916-22. doi: 10.1016/j.crohns.2012.12.012. Epub 2013 Jan 20.

PMID:
23339932
6.

Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up.

Ohkusa T, Nomura T, Terai T, Miwa H, Kobayashi O, Hojo M, Takei Y, Ogihara T, Hirai S, Okayasu I, Sato N.

Scand J Gastroenterol. 2005 Nov;40(11):1334-42.

PMID:
16334443
7.

Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.

Turner D, Griffiths AM, Veerman G, Johanns J, Damaraju L, Blank M, Hyams J.

Clin Gastroenterol Hepatol. 2013 Nov;11(11):1460-5. doi: 10.1016/j.cgh.2013.04.049. Epub 2013 May 11.

PMID:
23672831
8.

Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.

Molander P, Sipponen T, Kemppainen H, Jussila A, Blomster T, Koskela R, Nissinen M, Rautiainen H, Kuisma J, Kolho KL, Färkkilä M.

J Crohns Colitis. 2013 Oct;7(9):730-5. doi: 10.1016/j.crohns.2012.10.018. Epub 2012 Nov 21.

PMID:
23182163
9.

Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.

Ruuska T, Wewer V, Lindgren F, Malmborg P, Lindquist M, Marthinsen L, Browaldh L, Casswall T, Kalliomäki M, Grönlund J.

Inflamm Bowel Dis. 2009 Jul;15(7):1049-54. doi: 10.1002/ibd.20859.

PMID:
19137602
10.

Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.

Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A.

Inflamm Bowel Dis. 2015 Aug;21(8):1739-49. doi: 10.1097/MIB.0000000000000437.

PMID:
26185909
11.

Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.

Cucchiara S, Romeo E, Viola F, Cottone M, Fontana M, Lombardi G, Rutigliano V, de'Angelis GL, Federici T.

Dig Liver Dis. 2008 Jul;40 Suppl 2:S260-4. doi: 10.1016/S1590-8658(08)60535-6.

PMID:
18598998
12.

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.

Navas-López VM, Blasco Alonso J, Serrano Nieto MJ, Girón Fernández-Crehuet F, Argos Rodriguez MD, Sierra Salinas C.

J Crohns Colitis. 2014 Jan;8(1):64-9. doi: 10.1016/j.crohns.2013.03.006. Epub 2013 Apr 9.

PMID:
23582736
13.

Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.

Absah I, Faubion WA Jr.

Inflamm Bowel Dis. 2012 Aug;18(8):1488-92. doi: 10.1002/ibd.21885. Epub 2011 Aug 31.

PMID:
21882301
14.
15.

Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease.

Levine A, Turner D.

J Crohns Colitis. 2011 Jun;5(3):222-6. doi: 10.1016/j.crohns.2011.01.006. Epub 2011 Mar 30.

PMID:
21575885
16.

Cyclosporine A for induction of remission in severe ulcerative colitis.

Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004277. Review.

PMID:
15674937
17.

Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M.

Dig Liver Dis. 2002 Sep;34(9):626-30.

PMID:
12405248
18.

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.

Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, Panaccione R, Steinhart AH, Tse F, Feagan B; Toronto Ulcerative Colitis Consensus Group.

Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4. Review.

PMID:
25747596
19.

The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children.

Mutalib M, Borrelli O, Blackstock S, Kiparissi F, Elawad M, Shah N, Lindley K.

J Crohns Colitis. 2014 Dec;8(12):1730-4. doi: 10.1016/j.crohns.2014.08.014. Epub 2014 Sep 18.

PMID:
25240477
20.

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, Talley NJ, Moayyedi P.

Am J Gastroenterol. 2011 Apr;106(4):661-73. doi: 10.1038/ajg.2011.72. Epub 2011 Mar 15. Review. Erratum in: Am J Gastroenterol. 2011 May;106(5):1014. Abadir, A [corrected to Abadir, Amir].

PMID:
21407187

Supplemental Content

Support Center